Gossamer Bio
GOSS
GOSS
160 hedge funds and large institutions have $1.02B invested in Gossamer Bio in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
24% more funds holding
Funds holding: 129 → 160 (+31)
8.12% more ownership
Funds ownership: 82.59% → 90.71% (+8.1%)
Holders
160
Holding in Top 10
5
Calls
$17.2M
Puts
$6.58M
Top Buyers
| 1 | +$49.8M | |
| 2 | +$41.5M | |
| 3 | +$35.9M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$33.2M |
| 5 |
VA
VR Adviser
New York
|
+$20.9M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$18.6M | |
| 3 | -$15.9M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$14.9M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$10.9M |